Results 261 to 270 of about 2,962,665 (347)

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

open access: yesMolecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang   +3 more
wiley   +1 more source

Don't Stop Me Now, `Cause I'm Having a Good Time Screening: Evaluation of Stopping Methods for Safe Use of Priority Screening in Systematic Reviews. [PDF]

open access: yesCochrane Evid Synth Methods
Repke T   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy